시장보고서
상품코드
2108248

신장 장기 칩 시장 분석 및 예측(-2035년) : 유형, 제품 유형, 기술, 구성 요소, 용도, 재료 유형, 최종 사용자, 기능, 솔루션

Kidney Organ Chip Market Analysis and Forecast to 2035: Type, Product, Technology, Component, Application, Material Type, End User, Functionality, Solutions

발행일: | 리서치사: 구분자 Global Insight Services | 페이지 정보: 영문 350 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 4,750 금액 안내 화살표 ₩ 6,622,000
PDF & Excel (Site License) help
PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.
US $ 5,750 금액 안내 화살표 ₩ 8,017,000
PDF & Excel (Enterprise License) help
PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.
US $ 6,750 금액 안내 화살표 ₩ 9,411,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 신장 장기 칩 시장은 2025년 2억 3,190만 달러에서 2035년까지 15억 3,470만 달러로 성장하여 CAGR은 20.8%를 나타낼 것으로 예측됩니다. 신장 장기 칩 시장은 적당히 통합된 구조를 특징으로 하며, 주요 부문으로는 시장의 약 45%를 차지하는 약물 시험 용도와 약 30%를 차지하는 질환 모델링이 있습니다. 그 밖의 주요 용도로는 독성 시험 및 맞춤형 의료 등이 있습니다. 이 시장은 마이크로플루이딕스공학 및 장기 칩 기술의 발전에 힘입어 성장하고 있습니다. 도입 대수 동향을 보면, 연구 기관 및 제약 기업에서의 도입 대수가 증가하고 있는 것으로 나타나며, 이는 장기 칩 기술의 채택 확대를 반영하고 있습니다.

용도별로 보면, 신장 장기 칩 시장은 신약 개발, 독성학 연구, 질환 모델링, 맞춤형 의료, 기타로 분류됩니다. 이 중 2025년에는 신약 개발 부문이 가장 큰 시장 점유율을 차지했습니다. 이러한 우위는 제약 및 생명공학 기업들이 신약 개발 효율을 높이고 기존의 동물 실험 모델에 대한 의존도를 낮추기 위해 신장 장기 칩 기술의 도입을 확대하고 있기 때문입니다. 신장 온칩 플랫폼은 통제된 실험실 환경에서 인간의 신장 기능을 재현함으로써, 약물의 효능, 흡수성, 독성 및 신장 반응을 정확하게 평가할 수 있게 해줍니다. 첨단 전임상시험 기법에 대한 수요 증가, 제약 분야의 연구개발 투자 확대, 그리고 신약 개발 비용 및 실패율 저하에 대한 요구가 신장 장기 칩의 신약 개발 분야 도입을 더욱 촉진하고 있습니다.

기술별로 보면, 신장 장기 칩 시장은 마이크로플루이딕스, 3D 세포 배양, 오가노이드 기술, 기타로 분류됩니다. 이 중 오가노이드 기술 부문은 예측 기간 동안 가장 빠른 성장을 보일 것으로 전망됩니다. 이 부문의 급속한 확대는 줄기세포 연구 및 조직공학의 발전, 그리고 생리학적으로 더 적절한 인간 조직 모델의 개발이 진행되고 있는 데 기인합니다. 오가노이드 기반 신장 칩은 복잡한 신장의 구조와 기능을 더 충실하게 재현할 수 있으므로, 질환 모델링, 맞춤형 의료, 그리고 치료법 연구에 유용합니다. 재생 의학에 대한 투자 확대, 학술 기관과 생명공학 기업 간의 협력 강화, 그리고 환자 맞춤형 검사 플랫폼에 대한 수요 증가로 인해 신장 오가노이드 칩 시장에서 오가노이드 기술의 도입이 가속화될 것으로 예측됩니다.

지역별 개요

2025년, 북미는 선진적인 생의학 연구 인프라, 장기-온-칩 기술에 대한 막대한 투자, 그리고 제약 및 생명공학 기업의 강력한 입지 덕분에 신장 장기 칩 시장에서 가장 큰 점유율을 차지했습니다. 이 지역에서는 동물 실험 감축에 초점을 맞추면서, 의약품 안전성 평가 및 질환 모델링 개선을 도모하는 연구가 적극적으로 지원되고 있습니다. 주요 대학, 정부 자금 지원 연구 기관 및 생명공학 스타트업 기업들이 미세생리학적 시스템과 정밀 의학 이니셔티브에 지속적으로 투자하고 있습니다. 생명과학 연구 개발에 대한 강력한 자금 지원과 학계 및 산업계 간의 협력 강화로 인해 신장 장기 칩 개발 분야에서 북미의 리더십은 계속해서 견고해지고 있습니다.

아시아태평양은 생명공학 연구에 대한 투자 증가, 제약 산업의 확대, 그리고 첨단 생의학 기술에 대한 정부의 지원 강화로 인해 예측 기간 동안 가장 빠른 성장이 예상됩니다. 중국, 일본, 한국, 싱가포르 등의 국가들은 민관 협력 및 정밀 의학 이니셔티브에 대한 막대한 자금 지원을 통해 연구 역량을 강화하고 있습니다. 혁신적인 신약 개발 플랫폼에 대한 수요 증가, 학술 연구 활동의 확대, 그리고 동물 실험 대체법에 대한 관심 고조가 이 지역에서의 보급을 뒷받침하고 있습니다. 지속적인 기술 발전과 국제적인 연구 협력의 확대에 힘입어 아시아태평양 전체 시장 확대가 가속화될 것으로 예측됩니다.

주요 동향 및 성장 촉진요인

고도화된 전임상 약물 시험에 대한 수요 증가 :

예측 정확도가 높고 인간의 생리 기능에 부합하는 전임상시험 모델에 대한 수요가 증가함에 따라, 신장 장기 칩 시장의 주요 성장 촉진요인으로 작용하고 있습니다. 제약 회사와 생명공학 기업들은 동물 실험에 대한 의존도를 낮추면서도 약물의 안전성, 신독성 및 치료 효과 평가를 개선하기 위해 신장 장기 칩 기술을 도입하고 있습니다. 이러한 미세 생리학적 시스템은 인간의 신장 기능을 충실히 재현하여, 질병의 기전이나 약물에 대한 반응을 보다 정확하게 평가할 수 있게 해줍니다. 정밀 의학, 맞춤형 치료 및 장기 칩 연구에 대한 투자 증가가 이러한 도입을 더욱 가속화하고 있습니다. 신약 개발 효율을 높이고 후기 임상시험에서의 실패를 줄일 수 있다는 점이 계속해서 시장 성장을 뒷받침하고 있습니다.

인공지능과 '장기 칩' 플랫폼의 통합 :

신장 장기 칩 시장의 주요 동향 중 하나는 인공지능(AI) 및 첨단 데이터 분석을 장기 칩 기술과 통합하는 것입니다. AI 기반 소프트웨어는 복잡한 생물학적 반응 분석, 이미지 처리 자동화, 그리고 대규모 실험 데이터셋에 기반한 약물 독성 예측에 점점 더 많이 활용되고 있습니다. 또한 연구자들은 실험의 재현성을 높이고 신약 개발 과정을 가속화하기 위해 신장 칩을 클라우드 기반 플랫폼 및 머신러닝 알고리즘과 결합하고 있습니다. 마이크로플루이딕스공학, 계산생물학, AI의 이러한 융합을 통해 연구 효율이 향상될 뿐만 아니라, 보다 정확한 질환 모델링과 맞춤형 치료법 개발이 가능해졌습니다.

목차

제1장 주요 요약

제2장 시장 하이라이트

제3장 시장 역학

제4장 부문별 분석

제5장 지역별 분석

제6장 시장 전략

제7장 경쟁 정보

제8장 기업 개요

제9장 회사 소개

KTH 26.08.20

The global Kidney Organ Chip Market is projected to grow from $231.9 million in 2025 to $1,534.7 million by 2035, at a compound annual growth rate (CAGR) of 20.8%. The Kidney Organ Chip Market is characterized by a moderately consolidated structure, with the top segments being drug testing applications, accounting for approximately 45% of the market, and disease modeling, holding around 30%. Other significant applications include toxicity testing and personalized medicine. The market is driven by advancements in microfluidics and organ-on-chip technology. Volume insights suggest a growing number of installations in research institutions and pharmaceutical companies, reflecting increased adoption of organ chip technology.

Based on Application, the Kidney Organ Chip Market is divided into Drug Discovery, Toxicology Research, Disease Modeling, Personalized Medicine, and Others. Among these, the Drug Discovery segment accounted for the largest market share in 2025. This dominance is attributed to the increasing adoption of kidney organ chip technology by pharmaceutical and biotechnology companies to improve drug development efficiency and reduce dependency on traditional animal testing models. Kidney-on-a-chip platforms enable accurate evaluation of drug efficacy, absorption, toxicity, and renal responses by replicating human kidney functions under controlled laboratory conditions. The growing demand for advanced preclinical testing methods, rising pharmaceutical R&D investments, and the need to reduce drug development costs and failure rates are further driving the adoption of kidney organ chips in drug discovery applications.

Market Segmentation
TypeSingle-Organ Chip, Multi-Organ Chip, Others
ProductKidney-on-a-Chip Devices, Consumables, Others
TechnologyMicrofluidics, 3D Cell Culture, Organoid Technology, Others
ComponentMicrochannels, Membranes, Sensors, Others
ApplicationDrug Discovery, Toxicology Research, Disease Modeling, Personalized Medicine, Others
Material TypePolymers, Silicon, Glass, Others
End UserPharmaceutical Companies, Biotechnology Firms, Academic Research Institutes, Contract Research Organizations, Others
FunctionalityFiltration, Reabsorption, Secretion, Others
SolutionsPrototyping, Custom Development, Standardized Solutions, Others

Based on Technology, the Kidney Organ Chip Market is divided into Microfluidics, 3D Cell Culture, Organoid Technology, and Others. Among these, the Organoid Technology segment is projected to witness the fastest growth during the forecast period. The rapid expansion of this segment is driven by increasing advancements in stem cell research, tissue engineering, and the development of more physiologically relevant human tissue models. Organoid-based kidney chips offer improved representation of complex renal structures and functions, making them valuable for disease modeling, personalized medicine, and therapeutic research. Growing investments in regenerative medicine, increasing collaborations between academic institutions and biotechnology companies, and the rising demand for patient-specific testing platforms are expected to accelerate the adoption of organoid technology in the kidney organ chip market.

Geographical Overview

North America accounted for the largest share of the Kidney Organ Chip Market in 2025 owing to its advanced biomedical research infrastructure, significant investments in organ-on-chip technologies, and strong presence of pharmaceutical and biotechnology companies. The region actively supports research focused on reducing animal testing while improving drug safety evaluation and disease modeling. Leading universities, government-funded research institutions, and biotechnology startups are continuously investing in microphysiological systems and precision medicine initiatives. Strong funding for life science research and increasing collaboration between academia and industry continue to reinforce North America's leadership in kidney organ chip development.

Asia-Pacific is expected to witness the fastest growth during the forecast period due to increasing investments in biotechnology research, expanding pharmaceutical industries, and growing government support for advanced biomedical technologies. Countries including China, Japan, South Korea, and Singapore are strengthening research capabilities through public-private collaborations and substantial funding for precision medicine initiatives. Rising demand for innovative drug discovery platforms, expanding academic research activities, and growing interest in alternatives to animal testing are driving regional adoption. Continuous technological advancements and increasing international research collaborations are expected to accelerate market expansion across Asia-Pacific.

Key Trends and Drivers

Growing Demand for Advanced Preclinical Drug Testing:

The increasing need for more predictive and human-relevant preclinical testing models is a major driver for the Kidney Organ Chip Market. Pharmaceutical and biotechnology companies are adopting kidney organ chip technologies to improve the evaluation of drug safety, nephrotoxicity, and therapeutic efficacy while reducing reliance on animal testing. These microphysiological systems closely mimic human kidney functions, enabling more accurate assessment of disease mechanisms and drug responses. Rising investments in precision medicine, personalized therapeutics, and organ-on-chip research are further accelerating adoption. The ability to improve drug development efficiency and reduce late-stage clinical failures continues to support market growth.

Integration of Artificial Intelligence with Organ-on-Chip Platforms:

A significant trend in the Kidney Organ Chip Market is the integration of artificial intelligence and advanced data analytics with organ-on-chip technologies. AI-powered software is increasingly being used to analyze complex biological responses, automate image processing, and predict drug toxicity based on large experimental datasets. Researchers are also combining kidney chips with cloud-based platforms and machine learning algorithms to enhance experimental reproducibility and accelerate drug discovery. This convergence of microfluidics, computational biology, and AI is improving research efficiency while enabling more accurate disease modeling and personalized therapeutic development.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Component
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Material Type
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Single-Organ Chip
    • 4.1.2 Multi-Organ Chip
    • 4.1.3 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Kidney-on-a-Chip Devices
    • 4.2.2 Consumables
    • 4.2.3 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Microfluidics
    • 4.3.2 3D Cell Culture
    • 4.3.3 Organoid Technology
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Component (2020-2035)
    • 4.4.1 Microchannels
    • 4.4.2 Membranes
    • 4.4.3 Sensors
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Drug Discovery
    • 4.5.2 Toxicology Research
    • 4.5.3 Disease Modeling
    • 4.5.4 Personalized Medicine
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by Material Type (2020-2035)
    • 4.6.1 Polymers
    • 4.6.2 Silicon
    • 4.6.3 Glass
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Pharmaceutical Companies
    • 4.7.2 Biotechnology Firms
    • 4.7.3 Academic Research Institutes
    • 4.7.4 Contract Research Organizations
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Filtration
    • 4.8.2 Reabsorption
    • 4.8.3 Secretion
    • 4.8.4 Others
  • 4.9 Market Size & Forecast by Solutions (2020-2035)
    • 4.9.1 Prototyping
    • 4.9.2 Custom Development
    • 4.9.3 Standardized Solutions
    • 4.9.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Component
      • 5.2.1.5 Application
      • 5.2.1.6 Material Type
      • 5.2.1.7 End User
      • 5.2.1.8 Functionality
      • 5.2.1.9 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Component
      • 5.2.2.5 Application
      • 5.2.2.6 Material Type
      • 5.2.2.7 End User
      • 5.2.2.8 Functionality
      • 5.2.2.9 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Component
      • 5.2.3.5 Application
      • 5.2.3.6 Material Type
      • 5.2.3.7 End User
      • 5.2.3.8 Functionality
      • 5.2.3.9 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Component
      • 5.3.1.5 Application
      • 5.3.1.6 Material Type
      • 5.3.1.7 End User
      • 5.3.1.8 Functionality
      • 5.3.1.9 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Component
      • 5.3.2.5 Application
      • 5.3.2.6 Material Type
      • 5.3.2.7 End User
      • 5.3.2.8 Functionality
      • 5.3.2.9 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Component
      • 5.3.3.5 Application
      • 5.3.3.6 Material Type
      • 5.3.3.7 End User
      • 5.3.3.8 Functionality
      • 5.3.3.9 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Component
      • 5.4.1.5 Application
      • 5.4.1.6 Material Type
      • 5.4.1.7 End User
      • 5.4.1.8 Functionality
      • 5.4.1.9 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Component
      • 5.4.2.5 Application
      • 5.4.2.6 Material Type
      • 5.4.2.7 End User
      • 5.4.2.8 Functionality
      • 5.4.2.9 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Component
      • 5.4.3.5 Application
      • 5.4.3.6 Material Type
      • 5.4.3.7 End User
      • 5.4.3.8 Functionality
      • 5.4.3.9 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Component
      • 5.4.4.5 Application
      • 5.4.4.6 Material Type
      • 5.4.4.7 End User
      • 5.4.4.8 Functionality
      • 5.4.4.9 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Component
      • 5.4.5.5 Application
      • 5.4.5.6 Material Type
      • 5.4.5.7 End User
      • 5.4.5.8 Functionality
      • 5.4.5.9 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Component
      • 5.4.6.5 Application
      • 5.4.6.6 Material Type
      • 5.4.6.7 End User
      • 5.4.6.8 Functionality
      • 5.4.6.9 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Component
      • 5.4.7.5 Application
      • 5.4.7.6 Material Type
      • 5.4.7.7 End User
      • 5.4.7.8 Functionality
      • 5.4.7.9 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Component
      • 5.5.1.5 Application
      • 5.5.1.6 Material Type
      • 5.5.1.7 End User
      • 5.5.1.8 Functionality
      • 5.5.1.9 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Component
      • 5.5.2.5 Application
      • 5.5.2.6 Material Type
      • 5.5.2.7 End User
      • 5.5.2.8 Functionality
      • 5.5.2.9 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Component
      • 5.5.3.5 Application
      • 5.5.3.6 Material Type
      • 5.5.3.7 End User
      • 5.5.3.8 Functionality
      • 5.5.3.9 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Component
      • 5.5.4.5 Application
      • 5.5.4.6 Material Type
      • 5.5.4.7 End User
      • 5.5.4.8 Functionality
      • 5.5.4.9 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Component
      • 5.5.5.5 Application
      • 5.5.5.6 Material Type
      • 5.5.5.7 End User
      • 5.5.5.8 Functionality
      • 5.5.5.9 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Component
      • 5.5.6.5 Application
      • 5.5.6.6 Material Type
      • 5.5.6.7 End User
      • 5.5.6.8 Functionality
      • 5.5.6.9 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Component
      • 5.6.1.5 Application
      • 5.6.1.6 Material Type
      • 5.6.1.7 End User
      • 5.6.1.8 Functionality
      • 5.6.1.9 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Component
      • 5.6.2.5 Application
      • 5.6.2.6 Material Type
      • 5.6.2.7 End User
      • 5.6.2.8 Functionality
      • 5.6.2.9 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Component
      • 5.6.3.5 Application
      • 5.6.3.6 Material Type
      • 5.6.3.7 End User
      • 5.6.3.8 Functionality
      • 5.6.3.9 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Component
      • 5.6.4.5 Application
      • 5.6.4.6 Material Type
      • 5.6.4.7 End User
      • 5.6.4.8 Functionality
      • 5.6.4.9 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Component
      • 5.6.5.5 Application
      • 5.6.5.6 Material Type
      • 5.6.5.7 End User
      • 5.6.5.8 Functionality
      • 5.6.5.9 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Emulate
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 CN Bio Innovations
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Mimetas
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 TissUse
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Hesperos
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Kirkstall
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Nortis
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 InSphero
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Organovo
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 AxoSim
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 BiomimX
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Tara Biosystems
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 AlveoliX
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Hurel Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Elveflow
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Cherry Biotech
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 SynVivo
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Micronit
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 QurAlis
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 BioIVT
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기